Buckley Kohlhauff
Chief Tech/Sci/R&D Officer at NURIX THERAPEUTICS, INC.
Buckley Kohlhauff active positions
Companies | Position | Start | End |
---|---|---|---|
NURIX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/08/2021 | - |
Career history of Buckley Kohlhauff
Former positions of Buckley Kohlhauff
Companies | Position | Start | End |
---|---|---|---|
LEXICON PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - | - |
FIVE PRIME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - | - |
Training of Buckley Kohlhauff
Carnegie Mellon University | Undergraduate Degree |
Statistics
International
United States | 5 |
Operational
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
NURIX THERAPEUTICS, INC. | Health Technology |
LEXICON PHARMACEUTICALS, INC. | Health Technology |
Private companies | 1 |
---|---|
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc. BiotechnologyHealth Technology Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, C. | Health Technology |
- Stock Market
- Insiders
- Buckley Kohlhauff
- Experience